New Zealand markets close in 1 hour 36 minutes

Avenue Therapeutics, Inc. (ATXI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.4000+0.2000 (+4.76%)
At close: 04:00PM EDT
4.3450 -0.06 (-1.25%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.45M
Enterprise value 670.56k
Trailing P/E N/A
Forward P/E 17.99
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.55
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.07

Trading information

Stock price history

Beta (5Y monthly) -0.26
52-week change 3-94.30%
S&P500 52-week change 325.59%
52-week high 393.7500
52-week low 34.0400
50-day moving average 310.0729
200-day moving average 327.9564

Share statistics

Avg vol (3-month) 358.49k
Avg vol (10-day) 3248.84k
Shares outstanding 5595.52k
Implied shares outstanding 6595.52k
Float 8520.59k
% held by insiders 111.66%
% held by institutions 12.93%
Shares short (15 Apr 2024) 42.58k
Short ratio (15 Apr 2024) 40.19
Short % of float (15 Apr 2024) 40.44%
Short % of shares outstanding (15 Apr 2024) 40.44%
Shares short (prior month 15 Mar 2024) 44.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:75
Last split date 326 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-209.03%
Return on equity (ttm)-535.10%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-10.38M
Diluted EPS (ttm)-73.5000
Quarterly earnings growth (yoy)11.30%

Balance sheet

Total cash (mrq)1.78M
Total cash per share (mrq)3.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.55
Book value per share (mrq)4.64

Cash flow statement

Operating cash flow (ttm)-9.45M
Levered free cash flow (ttm)-13.49M